Cardiovascular Systems, Inc. (CSII) financial statements (2021 and earlier)
Company profile
| Business Address |
1225 OLD HWY 8 NW ST. PAUL, MN 55112 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 TTM | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 225 | 232 | 123 | 117 | 109 | 61 | 86 | ||
| Cash and cash equivalents | 74 | 185 | 74 | 116 | 108 | 61 | 84 | ||
| Short-term investments | 151 | 47 | 48 | 1 | 1 | 1 | 2 | ||
| Receivables | 33 | 25 | 36 | 31 | 28 | 23 | 31 | ||
| Inventory, net of allowances, customer advances and progress billings | 33 | 28 | 18 | 17 | 17 | 17 | 14 | ||
| Inventory | 33 | 28 | 18 | 17 | 17 | 17 | 14 | ||
| Other undisclosed current assets | 3 | 3 | 3 | 3 | 5 | 3 | 3 | ||
| Total current assets: | 293 | 288 | 180 | 168 | 159 | 105 | 134 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 28 | 28 | 27 | 28 | 30 | 32 | 33 | ||
| Intangible assets, net (including goodwill) | 16 | 17 | 5 | 5 | 5 | 5 | 5 | ||
| Intangible assets, net (excluding goodwill) | 16 | 17 | 5 | 5 | 5 | 5 | 5 | ||
| Other noncurrent assets | 12 | 7 | 6 | 3 | 0 | 0 | 0 | ||
| Total noncurrent assets: | 56 | 52 | 39 | 36 | 35 | 38 | 37 | ||
| TOTAL ASSETS: | 349 | 340 | 219 | 203 | 194 | 142 | 171 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 46 | 43 | 41 | 36 | 41 | 35 | 34 | ||
| Accounts payable | 14 | 12 | 11 | 10 | 11 | 9 | 10 | ||
| Accrued liabilities | 32 | 31 | 29 | 26 | 30 | 27 | 20 | ||
| Employee-related liabilities | 4 | ||||||||
| Deferred revenue | 2 | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 1 | |||||
| Other undisclosed current liabilities | 2 | (4) | |||||||
| Total current liabilities: | 48 | 45 | 42 | 37 | 41 | 35 | 30 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2 | ||||||||
| Operating lease, liability | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 6 | 5 | 1 | 10 | 13 | 6 | 2 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 9 | 10 | ||||
| Deferred revenue | 4 | 5 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 3 | 1 | 1 | 1 | 3 | 6 | 2 | ||
| Other undisclosed noncurrent liabilities | 19 | 21 | 28 | 21 | 21 | ||||
| Total noncurrent liabilities: | 27 | 26 | 28 | 31 | 35 | 6 | 2 | ||
| Total liabilities: | 75 | 71 | 71 | 69 | 76 | 42 | 32 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 274 | 269 | 148 | 134 | 118 | 101 | 139 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 643 | 632 | 477 | 462 | 448 | 428 | 411 | ||
| Accumulated other comprehensive income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Accumulated deficit | (369) | (363) | (330) | (328) | (329) | (327) | (271) | ||
| Total stockholders' equity: | 274 | 269 | 148 | 134 | 118 | 101 | 139 | ||
| TOTAL LIABILITIES AND EQUITY: | 349 | 340 | 219 | 203 | 194 | 142 | 171 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 TTM | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 228 | 237 | 248 | 217 | 205 | 178 | 182 | |
| Revenue, net | ✕ | ✕ | ✕ | 217 | 205 | 178 | 182 | |
| Cost of revenue | (49) | (49) | (48) | (39) | (39) | (35) | (40) | |
| Cost of goods and services sold | (39) | (39) | (35) | (40) | ||||
| Gross profit: | 180 | 188 | 200 | 178 | 165 | 143 | 142 | |
| Operating expenses | (198) | (215) | (201) | (175) | (167) | (199) | (175) | |
| Operating income (loss): | (19) | (27) | (1) | 2 | (2) | (56) | (33) | |
| Nonoperating income (expense) | (1) | (0) | 1 | (0) | (0) | 0 | (0) | |
| Other nonoperating income (expense) | (0) | 0 | (0) | |||||
| Interest and debt expense | (2) | (2) | (2) | (2) | (1) | (0) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (22) | (29) | (2) | 0 | (2) | (56) | (33) | |
| Other undisclosed income from continuing operations before income taxes | 2 | 2 | 2 | 2 | 1 | |||
| Income (loss) from continuing operations before income taxes: | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
| Income tax expense | (0) | (0) | (0) | (0) | (0) | |||
| Net income (loss): | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
| Other undisclosed net income attributable to parent | 0 | |||||||
| Net income (loss) attributable to parent: | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
| Undistributed earnings (loss) allocated to participating securities, basic | 0 | ✕ | ✕ | ✕ | ||||
| Net income (loss) available to common stockholders, diluted: | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
Comprehensive Income ($ in millions)
| 12/31/2020 TTM | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
| Other comprehensive income | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed comprehensive income | 0 | |||||||
| Comprehensive income (loss): | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (0) | (0) | (0) | (0) | 0 | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (20) | (27) | (0) | 2 | (2) | (56) | (33) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.